AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2015
Oct 2, 2015
35066_dirs_2015-10-02_5aa7cf34-2c8d-41f7-a9cb-8760499aaffd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2015-10-01
Reporting Person: Mayers Douglas L (N/A)
More from Cocrystal Pharma, Inc.
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15